It's been five less than satisfying years that companies have had to live with the Sarbanes-Oxley Act, but for the first time there is less fear and loathing and more hope that the new guidance from the SEC and Auditing Standard 5 could turn SOX into something that might actually...
Sarbanes-Oxley:Risk of Too Little RiskWhile much of the criticism of Sarbanes-Oxley has focused on Section 404 costs, a new study suggests that the greater damage ...
Wyeth, the $20.4 billion research-driven pharmaceutical and healthcare products company, with headquarters in Madison, N.J., elected Greg Norden senior vice president and CFO. Norden, 49, ...